LONDON, UNITED KINGDOM--(Marketwired - November 30, 2016) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) (“Plandaí” or “the Company”), producer of the highly bioavailable Phytofare® catechin complex, is pleased to announce that they have received an initial purchase order from Capital Brands LLC, distributor of the world famous, NutriBullet®, who will feature Phytofare® Catechin Complex as an active ingredient in their nutrient extraction powder mix, “Superfood Fat Burning Boost®" which will be for sale exclusively in the USA early in Q1 2017. NutriBullet, the maker of the popular nutrient extraction blender, has formulated superfoods containing pea protein, fibers, antioxidants, and vitamins that can be easily combined into healthy smoothies. The company uses GMO-free ingredients sourced from the world’s most reputable farms that undergo extensive testing for purity, effectiveness and flavor.
Callum Cottrell-Duffield, Vice President of sales and marketing for Plandaí Biotechnology, commented, “We are excited that a company with such a sterling reputation for using quality sources for their ingredients has chosen to use our product to better their own. Phytofare® is the only green tea catechin extract backed by human clinical studies which confirms that it has ten times greater bioavailability over generic extracts. Green tea catechins have been widely studied and shown to promote weight loss by increasing thermogenesis; however, poor bioavailability has historically hampered their effectiveness except at high dosages, which can lead to nausea and other unwanted side effects. By using Phytofare® as the active ingredient, NutriBullet can deliver a product at lower dosage points, but with greater therapeutic benefit. We look forward to a long a mutually profitable relationship with NutriBullet LLC.”
Dr. Rockway, VP of R&D for Capital Brands LLC, added, “We take great pride in insuring not only do our products meet the highest quality standards, but also that we can deliver on the promises on our packaging. Adding Phytofare® Catechin Complex to our SuperFood Fat Burning Boost® is a significant value add for many reasons. Not only is Phytofare® Catechin Complex clinically proven in human studies to be a superior ingredient, but we are impressed with Plandaí’s commitment to providing economic empowerment to the South African people while also responsibly operating with a zero carbon footprint. These are all values that we as a company and our customers share with Plandaí.”
About Capital Brands LLC
Capital Brands LLC and its subsidiaries create, produce, and sell NutriBullet blenders as well as Superfood formula mixes and other accessories for their blenders that help give the consumer the best possible health benefits using only the best and most quality ingredients available. The company focuses on nutrient extraction in order to deliver the most nutrients possible from food and other ingredients to increase the health of people everywhere. For more information, please visit https://www.nutribullet.com/. “NutriBullet” and “SuperFood Fat Burning Boost” are the registered trademarks of Capbran Holdings, LLC.
About Plandaí Biotechnology, Inc.
Plandaí Biotechnology, Inc. and its subsidiaries develop highly phyto-available™ extracts. Plandaí Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing its proprietary Phytofare® extracts in-house, allowing the Company to guarantee the continuity of supply as well as quality control throughout the entire process. Targeted industries for the Company’s products include beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.
Safe Harbor Statement
This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance or guarantee that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous factors and uncertainties, including but not limited to: adverse economic conditions, competition, adverse federal, state and local government regulation, international governmental regulation, inadequate capital, inability to carry out research, development and commercialization plans, loss or retirement of key executives and other specific risks. To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Readers are advised to review our filings with the Securities and Exchange Commission that can be accessed over the Internet at the SEC’s website located at http://www.sec.gov.
CONTACT:
Plandai Biotechnology, Inc.
hmerrill@plandaibiotech.com
(435)-881-3611
